A study to evaluate the pharmacokinetics of Tezepelumab after being delivered by an accessorized pre filled syringe or autoinjector compared with vial and syringe in healthy adult subjects

Trial Identifier: D5180C00012
Sponsor: AstraZeneca
NCTID:: NCT03989544
Start Date: June 2019
Primary Completion Date: December 2019
Study Completion Date: December 2019
Condition: Asthma

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language Description
English Translation
German Translation

Trial Locations

Country Location
Germany Berlin, Germany, 14050